A Feasibility Study of Multimodal Exercise/Nutrition/Anti-inflammatory Treatment for Cachexia - the Pre-MENAC Study
18 Years
75 Years
Both
Cancer, Cachexia
Trial Information
A Feasibility Study of Multimodal Exercise/Nutrition/Anti-inflammatory Treatment for Cachexia - the Pre-MENAC Study
Inclusion Criteria
Main eligibility criteria:
- Advanced non-small-cell lung cancer (stage III-IV) or pancreatic cancer not eligible
for curative therapy
- Due to commence chemo- or chemo radiotherapy
- Karnofsky Performance Score ≥ 70
- A life expectancy of ≥4 months and considered able to complete 2 months of the study
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Outcome Measure:
Feasibility of recruitment and retention
Outcome Description:
The aim of this study is to investigate the feasibility of the multimodal intervention for cancer cachexia by assessing; enrolment rate, compliance with study intervention, contamination-rate in the control group with respect to any of the interventions.
Outcome Time Frame:
12 weeks
Safety Issue:
No
Principal Investigator
Stein Kaasa, MD, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
NTNU
Authority:
Norway:National Committee for Medical and Health Research Ethics
Study ID:
2010/2620 (REK)
NCT ID:
NCT01419145
Start Date:
October 2011
Completion Date:
December 2014
Related Keywords:
- Cancer
- Cachexia
- cachexia
- neoplasms
- complications
- Combined Modality Therapy
- exercise therapy
- diet therapy
- Anti-Inflammatory Agents
- Cachexia
Name | Location |
|---|
